William Blair & Company’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

William Blair & Company’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.1M	Buy	16,556 +5,601	+51%	+$328K	﹤0.01%	948
2026 Q1	$593K	Buy	10,955 +10,104	+1,187%	+$563K	﹤0.01%	1096
2025 Q4	$47.7K	Hold	851	–	–	﹤0.01%	1662
2025 Q3	$40.8K	Hold	851	–	–	﹤0.01%	1662
2025 Q2	$34.5K	Buy	851 +165	+24%	+$6.63K	﹤0.01%	1641
2025 Q1	$30.1K	Buy	+686	New	+$30.3K	﹤0.01%	1641
2022 Q1	–	Sell	-90	Closed	-$4K	–	2022
2021 Q4	$4K	Hold	90	–	–	﹤0.01%	1933
2021 Q3	$4K	Buy	90 +30	+50%	+$1.49K	﹤0.01%	1842
2021 Q2	$3K	Buy	+60	New	+$3.01K	﹤0.01%	1859
2020 Q2	–	Sell	-532	Closed	-$19K	–	1759
2020 Q1	$19K	Hold	532	–	–	﹤0.01%	1500
2019 Q4	$24K	Hold	532	–	–	﹤0.01%	1561
2019 Q3	$19K	Hold	532	–	–	﹤0.01%	1555
2019 Q2	$23K	Hold	532	–	–	﹤0.01%	1572
2019 Q1	$23K	Hold	532	–	–	﹤0.01%	1552
2018 Q4	$23K	Hold	532	–	–	﹤0.01%	1475
2018 Q3	$26K	Hold	532	–	–	﹤0.01%	1510
2018 Q2	$23K	Hold	532	–	–	﹤0.01%	1486
2018 Q1	$22K	Buy	+532	New	+$23.2K	﹤0.01%	1410

Other funds holding XPH

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

KWM

Kingsview Wealth Management Grants Pass, Oregon $8.25B AUM 24.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Envestnet Portfolio Solutions Chicago, Illinois $20.9B AUM 19.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Evelyn Partners London $46.9B AUM

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

William Blair & Company's XPH Position: Q2 2026 in Review

William Blair & Company increased its State Street SPDR S&P Pharmaceuticals ETF (XPH) stake by 51% in Q2 2026, buying an estimated $328K and bringing the position to 16,556 shares worth $1.1M. The position accounts for ﹤0.01% of the portfolio, ranked #948.

William Blair & Company first reported a position in XPH in Q1 2018 and has held it in 18 quarters since. 92 funds tracked by Wall St. Rank hold XPH as of Q2 2026.

William Blair & Company held 16,556 shares of State Street SPDR S&P Pharmaceuticals ETF worth $1.1M as of Q2 2026.
William Blair & Company bought 5,601 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2026, an estimated $328K.
State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of William Blair & Company's portfolio in Q2 2026, its #948 holding.
William Blair & Company first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q1 2018 and has held it in 18 quarters since.
92 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2026.

Based on William Blair & Company's 13F filing for Q2 2026, filed 11 Aug 2026.